Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
Science
; 369(6510): 1501-1505, 2020 09 18.
Article
in En
| MEDLINE
| ID: mdl-32703906
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand heat stress, storage at room temperature, and three freeze-thaw cycles. A cryo-electron microscopy structure of HexaPro at a resolution of 3.2 angstroms confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Amino Acid Substitution
/
Spike Glycoprotein, Coronavirus
/
Betacoronavirus
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Science
Year:
2020
Document type:
Article
Affiliation country:
Estados Unidos